WAVEMAN · COMPANY

ONMDW · Onemednet Corp

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

ONMDW

Name: OneMedNet Corp (ONMDW) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

OneMedNet Corp

PHARMA & BIOTECH · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · CIK 0001849380

SEC FILINGS☆ WATCH

INSIDER NET · 180D

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+88.4%

XBRL, annual

NET MARGIN

-743.8%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

no Form 4 purchases or sales on file

CONGRESS

no member of Congress has reported trading it

FUNDS

10 funds added or opened last quarter

below 82% of Pharma & Biotech

REVENUE

+88.4% year over year (latest quarter)

more than 84% of Pharma & Biotech

MARGIN

-743.8% net margin (latest quarter)

below 86% of Pharma & Biotech

BUYBACKS

no share repurchases reported

SHORT

<0.1% of shares outstanding short · 2.4 days to cover · settled 2026-07-31

below 93% of Pharma & Biotech

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows 10 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for OneMedNet Corp in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

Savant Capital, LLC

8,090,987.0 sh

$5.2M

VANGUARD CAPITAL MANAGEMENT LLC

1,152,210.0 sh

$819.2K

GEODE CAPITAL MANAGEMENT, LLC

334,332.0 sh

$237.7K

TORONTO DOMINION BANK

2,937,695.0 sh

$118.8K

VANGUARD FIDUCIARY TRUST CO

137,706.0 sh

$97.9K

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Fidelity Extended Market Index Fund

$153.3K POSITION · AS OF 2026-02-28

0.0%

VANGUARD EXTENDED MARKET INDEX FUND

$230.0K POSITION · AS OF 2026-03-31

0.0%

Avantis Total Equity Markets ETF

$927 POSITION · AS OF 2026-02-28

0.0%

Total Stock Market Index Trust

$991 POSITION · AS OF 2026-03-31

0.0%

Fidelity Nasdaq Composite Index Fund

$18.3K POSITION · AS OF 2026-02-28

0.0%

Fidelity Series Total Market Index Fund

$42.0K POSITION · AS OF 2026-02-28

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK